Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migraines
migraines
Antidepressant-Migraine Drug Combination Found Less Risky Than Believed
Forbes
Wed, 02/28/18 - 06:51 pm
migraines
antidepressants
triptans
Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble
Fierce Pharma
Thu, 02/22/18 - 11:28 pm
migraines
NASH
Amgen
Eli Lilly
Teva Pharmaceutical
Allergan
Gilead Sciences
Novo Nordisk
Intercept Pharma
PBMs
Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Yahoo/Market Realist
Wed, 02/21/18 - 09:47 am
Novartis
FDA
EMA
drug approvals
Aimovig
migraines
Will Allergan cannibalize Botox with ubrogepant?
Biopharma Dive
Fri, 02/9/18 - 10:06 am
Allergan
Botox
ubrogepant
migraines
Teva's Turnarond: Is It Ever Or Never?
Forbes
Thu, 02/8/18 - 11:53 pm
Teva Pharmaceutical
Copaxone
migraines
fremanezumab
In latest blow to Teva, CGRP migraine med delayed while rivals race towards the finish line
Endpoints
Thu, 02/8/18 - 09:40 am
Teva Pharmaceutical
migraines
CGRP blockers
fremanezumab
As Migraine Races Heat Up, Allergan Touts New Data for Headache Pill
Xconomy
Tue, 02/6/18 - 09:27 am
migraines
Allergan
ubrogepant
Teva, Alder ink migraine deal to avoid legal headache
Biopharma Dive
Tue, 01/9/18 - 10:53 pm
Teva Pharmaceutical
Alder Biopharmaceuticals
migraines
eptinezumab
Amgen pulls ahead in sprint towards CGRP approval with promising PhIII migraine data
Endpoints
Wed, 11/29/17 - 09:44 pm
Amgen
CGRP blockers
migraines
Aimovig
erenumab
Novartis spotlights its top 4 blockbuster late-stage pipeline projects
Endpoints
Mon, 11/13/17 - 09:35 am
Novartis
RTH258
wet age-related macular degeneration
AMG 334
migraines
Cosentyx
ACZ885
[forum discussion]New neuro sales force for Amgen migraine drug erenumab
Cafepharma Message Boards
Tue, 10/17/17 - 12:40 pm
Amgen
drug reps
hirings
migraines
erenumab
Eli Lilly says late-stage, 12-month study showed its migraine treatment was safe, effective
Marketwatch
Fri, 09/8/17 - 09:44 am
Eli Lilly
migraines
clinical trials
galcanezumab
Empathy at work: GlaxoSmithKline extends Excedrin Migraine campaign to include sufferers on the job
Fierce Pharma
Wed, 09/6/17 - 08:41 pm
GSK
Excederin Migraine
migraines
drug ads
DTC ads
Lilly's turn to pain gathers momentum
BioPharma Dive
Mon, 08/7/17 - 11:30 am
Eli Lilly
Lasmiditan
migraines
Lilly's acute migraine drug succeeds in late-stage study
Yahoo/Reuters
Fri, 08/4/17 - 11:35 am
Eli Lilly
migraines
clinical trials
Lasmiditan
Amgen And Novartis: First Mover Advantage Is A Must
Seeking Alpha
Mon, 07/24/17 - 11:55 pm
Amgen
Novartis
migraines
erenumab
CGRP blockers
Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK
Endpoints
Thu, 07/20/17 - 11:34 pm
Amgen
Novartis
migraines
CGRPs
Aimovig
Alder prices $150M offering to fund migraine market scrap
Fierce Biotech
Thu, 07/13/17 - 05:33 pm
Alder Biopharma
migraines
eptinezumab
Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field
Endpoints
Tue, 06/27/17 - 09:38 am
Alder Biopharma
migraines
clinical trials
eptinezumab
Eli Lilly
Amgen
Novartis
Merck
Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Endpoints
Sun, 06/11/17 - 04:58 pm
Eli Lilly
migraines
galcanezumab
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »